Irenic Capital Management LP Purchases 249,955 Shares of Sotera Health Company $SHC

Irenic Capital Management LP boosted its position in Sotera Health Company (NASDAQ:SHC) by 7.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,798,026 shares of the company’s stock after buying an additional 249,955 shares during the period. Sotera Health makes up 4.5% of Irenic Capital Management LP’s holdings, making the stock its 2nd biggest holding. Irenic Capital Management LP owned about 1.34% of Sotera Health worth $66,997,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of SHC. Sculptor Capital LP lifted its stake in Sotera Health by 57.4% in the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after buying an additional 7,658,200 shares during the period. Sachem Head Capital Management LP lifted its stake in Sotera Health by 47.2% in the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after buying an additional 3,735,000 shares during the period. Vanguard Group Inc. lifted its stake in Sotera Health by 16.7% in the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after buying an additional 2,756,583 shares during the period. AQR Capital Management LLC lifted its stake in Sotera Health by 1,206.2% in the fourth quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after buying an additional 2,644,831 shares during the period. Finally, Norges Bank bought a new stake in shares of Sotera Health in the 4th quarter valued at $45,278,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Down 3.6%

NASDAQ SHC opened at $15.46 on Thursday. The company has a market cap of $4.41 billion, a price-to-earnings ratio of 37.71 and a beta of 1.79. Sotera Health Company has a 52 week low of $10.84 and a 52 week high of $19.85. The business has a 50 day moving average price of $15.67 and a 200-day moving average price of $16.35. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities analysts expect that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on SHC shares. Citigroup lifted their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Barclays decreased their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and a consensus target price of $20.29.

Insider Activity at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.36% of the stock is currently owned by corporate insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.